-The Conference Forum is pleased to announce the launch of the 3rd annual Clinical Trial Collaborations conference in Boston on April 9-11, 2018. Industry veteran, Dr Jeremy Chadwick, Group VP, Clinical Development Operations, Shire Pharmaceuticals, and conference chair, Dr Murray Abramson address in a fireside chat what it takes to develop strateg
This clinical trial that received the approval of the FDA is Averas latest collaboration as part its membership in the Worldwide Innovative Networking Consortium. This latest step in our collaboration with WIN represents one clinical trial but is part of our larger goal to revolutionize cancer care through personalized medicine, said Benjamin Solom
Albany, NY 01/19/2018 Lately, the global pediatric vaccination market has been exhibiting a robust growth. Various upcoming child healthcare programs by UNICEF and the WHO are likely to boost this market in the near future. North America, Europe, Asia Pacific, and the Rest of the World are the key regional markets for pediatric vaccines in th
BOULDER, Colo. and CASTRES, France, Jan. 20, 2018/ PRNewswire/ Array BioPharma Inc. and Pierre Fabre today announced updated results from the 30 patient safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients
The Department of Justice announced today that a federal court in New Jersey imposed a $5 million civil penalty and entered a consent decree of permanent injunction against Dr. Reddys Laboratories Inc. Dr. Reddys is the North American subsidiary of Dr. Reddys Laboratories Limited, a pharmaceutical company headquartered in India. The case involves..
The share price of Dong-A ST, a pharmaceutical company, has been surging after the company announced its deal to transfer technology of DA-9801, a diabetic neuropathy treatment, to NeuroBo Pharmaceuticals, Thursday. Under the agreement, Dong-A ST will receive $2 million and a 5 percent stake in NeuroBo, with milestones of up to $178 million, follow
Albany, NY 01/19/2018 Dry powder inhalers are used to deliver drugs in dry powdered form to the lungs of patients suffering from respiratory disorders. Pulmonary drug delivery has been gaining attention and acceptance in the past few years in the treatment of respiratory disorders due to advantages such as faster drug absorption, high bioavai
Doug Ducey wants lawmakers to enact a grab-bag of laws and authorize new regulations- many on doctors- in a bid to curb opioid abuse and overdoses. Legislation being crafted for a special legislative session this coming week includes:. Christina Corieri, the governor's health adviser, said the package was crafted with input from various interests,
New York, NY 01/19/2018 Ebola viral infection was first observed in The Democratic Republic of Congo in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. Top drug companies such as Hemispherx Biopharma, Biochryst Pharmaceuticals, Nano Vircides, Serepata Therapeutics, NewLink Genetics and Mapp Biopharm
Exelixis, Inc. today announced the presentation of updated results from the Genentech- sponsored phase 1 b clinical trial of cobimetinib, an Exelixis- discovered MEK inhibitor, in combination with atezolizumab, an anti-PDL1 antibody discovered and developed by Genentech, a member of the Roche Group, in patients with metastatic colorectal cancer.
Genus Lifesciences, Allentown, Pennsylvania, has been assigned a patent developed by two co-inventors for "pharmaceutical compositions and methods of using the same." The co-inventors are Jeffrey M. Moshal, Allentown, Pennsylvania, and Michael Libman, Allentown, Pennsylvania. Written by Diptimayee Mishra; edited by Sudarshan Harpal.
Many of the major not-for-profit hospital groups have tried their hand an manufacturing and making generics to combat the shortages of medicines as well as the high costs of branded medications. This move bypasses the monopoly held by the pharmaceutical companies. Hospital groups that are joining hands in this venture include Intermountain Health,.
P.F. Laboratories, Totowa, New Jersey, Purdue Pharma, Stamford, Connecticut, and Purdue Pharmaceuticals, Wilson, North Carolina, have been assigned a patent developed by three co-inventors for a "pharmaceutical formulation containing gelling agent." The co-inventors are Curtis Wright, Rockport, Massachusetts, Benjamin Oshlack, Boca Raton, Florida,
The company announced the closing of its $58 million Series A round of financing, co-led by Polaris Partners, the founding investor that provided the initial seed funding, Versant Ventures and Roche Venture Fund. The company, based in North Cambridge, Massachusetts, also announced key leadership appointments including CEO Anthony J. Coyle, PhD, and
New York, NY 01/19/2018 Pharmaceutical outsourcing, principally for contract research organization and contract manufacturing organizations, has developed during past ten years, and signs are that it will continue to develop over the forecast period. Complete new outsourcing industry sectors, like high-throughput screening services, have beco
Regen Biopharma Inc. Files SEC Form NT 10- K, Notification of Inability To Timely File Form 10- K 405, 10- K, 10- KSB 405, 10- KSB, 10- KT, Or 10- KT405:. By a News Reporter-Staff News Editor at Journal of Transportation According to news reporting originating from Washington, D.C., by VerticalNews journalists, a U.S. Securities and Exchange Comm
Celltrion, a Korean biopharmaceutical firm, said Friday that its net profits soared 82.1 percent in 2017 from a year earlier on robust sales of its biosimilar drug Remsima overseas. Celltrion said its operating profit more than doubled to 517 billion won in 2017 from 253 billion won a year earlier. Celltrion also began selling another biosimilar dr
Bunker Hill Community College graduate and Pfizer employee Ana Maria Ovalle spoke with WGBH News' Kirk Carapezza about the issue. After completing an internship at a biopharma company in Cambridge, Ovalle landed a job at Pfizer where she works in a bio-chemical lab full-time. Companies like Pfizer traditionally hired associate degree recipients to
-SOHM, Inc. a globally-known generic pharmaceutical manufacturer, announces today that it has signed a binding Letter of Intent with a Canadian Institutional Investor for a sizable investment in SOHM. Management is confident that by incorporating blockchain technologies with its core business, SOHM will create a competitive advantage in the field o
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Current study results on Wellness have been published. According to news reporting originating in New York City, New York, by NewsRx journalists, research stated, "We present device standards for low-power non-invasive electrical brain stimulation devices classified as limite
Pfizer, a pharmaceutical company, issued the following news release:. Pfizer announced today findings from the U.S. UC Narrative survey1, 2 of ulcerative colitis patients and gastroenterologists. The U.S. survey findings are an initial analysis of a subset of the UC Narrative global survey, which was developed with input from the Global UC Narrativ
By a News Reporter-Staff News Editor at Investment Weekly News Walgreens Boots Alliance, Inc. announced financial results for the first quarter of fiscal 2018 which ended 30 November 2017. Overview of First Quarter Results Fiscal 2018 first quarter net earnings attributable to Walgreens Boots Alliance determined in accordance with GAAP decreased
Valley Cottage, NY 01/19/2018 Web based E-detailing is an interacting media platform wherein the pharmaceutical companies display their products sales presentation and brochures. Web based E-detailing allows the doctor or physician to look up to the medicines as per their requirement. The web based E-detailing is comparatively cost effective
Zealand receives FDA approval of its Investigational New Drug application for its Phase 3 program with dasiglucagon for treatment of congenital hyperinsulinism. Two Phase 3 trials are set to start within the coming months at leading centers in the U.S. and Europe. U.S. FDA and the European Commission have already granted orphan drug designation for
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Syed, Uwais M., filed on June 27, 2016, was made available online on January 4, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institution. The followi